QIN Yongwen, BAI Yuan. History and Development of Interventional Devices forCongenital Heart Diseases in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 309-312. DOI: 10.12290/xhyxzz.2021-0148
Citation: QIN Yongwen, BAI Yuan. History and Development of Interventional Devices forCongenital Heart Diseases in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 309-312. DOI: 10.12290/xhyxzz.2021-0148

History and Development of Interventional Devices forCongenital Heart Diseases in China

More Information
  • Corresponding author:

    QIN Yongwen  Tel: 86-21-31161263, E-mail: qyw2009@163.com

  • Received Date: February 02, 2021
  • Accepted Date: March 22, 2021
  • Issue Publish Date: May 29, 2021
  • The development of interventional devices for congenital heart diseases in China has experienced the stage of imitation, improvement and innovation. After more than 30 years of evolution, the structure and performance of the devices made in China have reached a relatively perfect level. The experiences of clinical application and long-term follow-up of hundreds of thousands of cases show that the interventional devices made in China for congenital heart disease have stable performance and reliable curative effect. Among them, the performance of devices made in China for ventricular septal defect is world leading. In recent years, the development and application of innovative occluders, such as absorbable occluders, have also demonstrated Chinese characteristics, and are expected to create brilliant achievements in this field.
  • [1]
    Zhao L, Chen L, Yang T, et al. Birth prevalence of congenital heart disease in China, 1980—2019: a systematic review and meta-analysis of 617 studies[J]. Eur J Epidemiol, 2020, 35: 631-642. DOI: 10.1007/s10654-020-00653-0
    [2]
    中国生物医学工程学会体外循环分会. 2019年中国心外科手术和体外循环数据白皮书[J]. 中国体外循环杂志, 2020, 18: 193-196. https://www.cnki.com.cn/Article/CJFDTOTAL-TWXH202004001.htm
    [3]
    Rashkind WJ, Miller WW. Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries[J]. JAMA, 1966, 196: 991-992. DOI: 10.1001/jama.1966.03100240125026
    [4]
    钱晋卿, 华仰德, 姜宏兰. 导管栓塞法关闭动脉导管14例体会[J]. 中华医学杂志, 1986, 66: 751-753. DOI: 10.3760/j:issn:0376-2491.1986.12.021
    [5]
    张伟华, 任森根. 采用Sideris钮扣装置经导管治疗左向右分流先天性心脏病8例报告[J]. 重庆医学, 1996, 25: 266-267. https://www.cnki.com.cn/Article/CJFDTOTAL-CQYX199605003.htm
    [6]
    蒋世良, 戴汝平, 赵世华. 应用Amplatzer封堵器治疗动脉导管未闭[J]. 中华放射学杂志, 1999, 33: 745. DOI: 10.3760/j.issn:1005-1201.1999.11.007
    [7]
    夏呈森, 朱卫华. 国产球囊导管经皮扩张成形术治疗小儿先天性肺动脉瓣狭窄30例报告[J]. 临床儿科杂志, 1993, 11: 96-98. https://www.cnki.com.cn/Article/CJFDTOTAL-LCAK199302014.htm
    [8]
    蒋世良, 金敬琳, 徐仲英, 等. 采用10F国产球囊导管介入治疗体重≥10 kg儿童肺动脉瓣狭窄[J]. 中国介入心脏病学杂志, 2014, 22: 545-548. DOI: 10.3969/j.issn.1004-8812.2014.09.001
    [9]
    秦永文, 胡建强, 赵仙先. 自制镍钛合金室间隔缺损封堵器的生物相容性研究[J]. 第二军医大学学报, 2001, 22: 1038-1040. DOI: 10.3321/j.issn:0258-879X.2001.11.014
    [10]
    秦永文, 赵仙先, 李卫萍, 等. 应用自制封堵器经导管闭合膜部室间隔缺损[J]. 介入放射学杂志, 2002, 11: 130-131. DOI: 10.3969/j.issn.1008-794X.2002.02.021
    [11]
    秦永文, 吴弘, 赵仙先, 等. 膜部瘤型室间隔缺损的介入治疗[J]. 介入放射学杂志, 2006, 15: 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200601002.htm
    [12]
    秦永文, 赵仙先, 吴弘, 等. 自制非对称型室间隔缺损封堵器的初步临床应用[J]. 介入放射学杂志, 2004, 13: 101-103. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200402002.htm
    [13]
    Qin Y, Chen J, Zhao X, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder[J]. Am J Cardiol, 2008, 101: 1781-1786. DOI: 10.1016/j.amjcard.2008.02.069
    [14]
    Bai Y, Xu XD, Li CY, et al. Complete atrioventricular block after percutaneous device closure of perimembranous ventricular septal defect: A single-center experience on 1046 cases[J]. Heart Rhythm, 2015, 12: 2132-2140. DOI: 10.1016/j.hrthm.2015.05.014
    [15]
    Apostolopoulou SC, Tsoutsinos A, Laskari C, et al. Large single centre experience with the CeraTM and CeraFlexTM occluders for closure of interatrial communications: usefulness of the flexible rotation feature[J]. Cardiovasc Interv Ther, 2018, 33: 70-76. DOI: 10.1007/s12928-016-0440-y
    [16]
    Sievert K, Yu J, Bertog S, et al. Post-market clinical follow-up with the patent foramen ovale closure device IrisFIT (Lifetech) in patients with stroke, transient ischemic attack or other thromboembolic events[J]. Cardiovasc Revasc Med, 2020: S1553-8389(20)30581-9. doi: 10.1016/j.carrev.2020.09.031.
    [17]
    宣斌, 秦永文, 胡建强, 等. 双侧无铆型房间隔缺损封堵器的实验研究[J]. 介入放射学杂志, 2006, 15: 683-685. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS200611014.htm
    [18]
    郑纯风. Parylene涂层封堵器在先天性心脏病治疗中的效果评价[J]. 中国医学装备, 2016: 91-94. https://www.cnki.com.cn/Article/CJFDTOTAL-YXZB201604030.htm
    [19]
    周勇, 张磊, 赵先仙, 等. 涤纶膜外套式镍钛合金室间隔缺损封堵器的制作[J]. 第二军医大学学报, 2012, 33: 1335-1338. https://www.cnki.com.cn/Article/CJFDTOTAL-DEJD201212014.htm
  • Related Articles

    [1]TIAN Kunling, CHEN Chuanning. Notch Signaling Pathway and Congenital Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 649-654. DOI: 10.12290/xhyxzz.2023-0594
    [2]ZHANG Lu, LI Jian. Castleman Disease in China: State-of-the-art Technology Before the Era of IL-6 Targeted Therapy[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 911-914. DOI: 10.12290/xhyxzz.2023-0227
    [3]XIAO Jiawang, ZHU Xianyang. Evolution of Interventional Treatment of Congenital Heart Disease in China[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 303-308. DOI: 10.12290/xhyxzz.2021-0157
    [4]ZHANG Hao, LI Shoujun, SU Zhanhao. Reflections on Improving the Diagnosis and Treatment of Congenital Heart Diseasein China: the Regionalization of Care for Congenital Heart Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 287-290. DOI: 10.12290/xhyxzz.20200280
    [5]Beyond the NICU: Comprehensive Care of the High-risk Infant(2015)[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(6): 449-449.
    [6]Cardiovascular Intervention: A Companion to Braunwald's Heart Disease(2016)[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(1): 65-65.
    [7]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [8]Ying ZHANG, Jin-song GAO, Jun-tao LIU, Hai-yuan LIU, Ying-na SONG, Xiao-ming GONG, Zhi-jing SUN. Effectiveness of B-lynch Suture in Treatment and Prevention of Postpartum Hemorrhage[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(2): 174-177. DOI: 10.3969/j.issn.1674-9081.2013.02.019
    [9]Ya-gang ZUO, Hong-wei WANG, Jia-bi WANG. Dual-wavelength Laser with 595 nm and 1064 nm Combination for Resistant Port-wine Stains[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 386-389. DOI: 10.3969/j.issn.1674-9081.2012.04.005
    [10]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
  • Cited by

    Periodical cited type(3)

    1. 赵红妃,殷海燕,汪露,汪小楠. 住院先心病患儿医疗恐惧现状及其影响因素分析. 中国临床研究. 2024(01): 147-151 .
    2. 朱鲜阳. 先天性心脏病介入治疗现状及进展. 临床军医杂志. 2022(04): 331-333+338 .
    3. 杨启才,任凌,徐闵,李正义. 先天性心脏病介入治疗术后血清钾、钠、氯水平变化及临床意义. 中国医药科学. 2022(09): 188-191 .

    Other cited types(3)

Catalog

    Article Metrics

    Article views (1587) PDF downloads (249) Cited by(6)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close